Skip to main content
Clinical Trials/ACTRN12620000691943
ACTRN12620000691943
Not yet recruiting
Phase 1

The validation of human cerebral oxygenation sensitivity and reproducibility of a novel MR-based device under dynamic conditions in healthy humans

A/Prof. Shieak Tzeng0 sites4 target enrollmentJune 22, 2020

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
A/Prof. Shieak Tzeng
Enrollment
4
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 22, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
A/Prof. Shieak Tzeng

Eligibility Criteria

Inclusion Criteria

  • 18\-50 years old
  • Generally healthy
  • Non\-smoker
  • People with a BMI 18\.5\-30 kg m^\-2

Exclusion Criteria

  • History of migraines
  • History of respiratory or cardiovascular disease or specific renal impairment.
  • Currently taking diuretics, antacids, proton pump inhibitors, or histamine blockers.
  • Under 18 or over 50 years of age
  • History of stroke or other neurological conditions
  • A contrast enhanced medical scan in the past week
  • There will also be a set of within\-trial cessation criteria: a resting heart rate above 140 bpm, a peripheral O2 saturation below 70%, subject intolerance or request, sudden headache or nausea, or mental abnormalities as assessed by a clinician (i.e.: confusion, incoordination of motor skills).

Outcomes

Primary Outcomes

Not specified

Similar Trials